Synlab AG (SYAB.DE) XETRA
Currency In EUR
- General
- Statistics
- Historical Data
- Profile
- Financials
Synlab AG
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
27000
First IPO Date
April 30, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Mathieu Floreani | Chairman of the Management Board & Chief Executive Officer | 2.39M | 1967 |
| Bartholomäus Wimmer | Founder & Independent Member of the Supervisory Board | 132,000 | 1962 |
| Sami Badarani | Chief Financial Officer & Member of Management Board | 1.5M | 1963 |
| Santiago Valor | Chief Medical Officer | 0 | N/A |
| Luis Vieira | Group Chief Strategy Officer | 0 | N/A |
| Robert Steinwander | Group Chief Operating Officer | 0 | N/A |
| Catharina Monster | Group Chief Human Resources Officer | 0 | N/A |
| Alexander Hagen | Group Head of Commercial & Marketing | 0 | N/A |
| Anna Niedl | Head of Investor Relations | 0 | N/A |
| Kimberly Urdahl | Group General Counsel & Group Chief Compliance Officer | 0 | N/A |
Description
SYNLAB AG delivers extensive clinical laboratory and medical diagnostic services to a diverse clientele, including insurance providers, hospitals, pharmacies, national health organizations, private doctors, clinics, patients, governmental bodies, and corporations, primarily within Europe. The company's offerings include specialized COVID-19 testing, alongside a full range of medical and veterinary diagnostic solutions. Its vast operational network encompasses approximately 500 laboratories and 1,800 blood collection centers, spanning 36 countries across four continents. Established in 1998, SYNLAB AG's corporate headquarters are located in Munich, Germany.
